🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Jeremy Grantham’s WST Holdings & Trades

First Buy
Q4 2019
Duration Held
7 Quarters
Largest Add
Q4 2019
+8,219 Shares
Current Position
5,660 Shares
$2.03 M Value

Jeremy Grantham's WST Position Overview

Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 5,660 shares of West Pharmaceutical Services, Inc. (WST) worth $2.03 M, representing 0.00% of the portfolio. First purchased in 2019-Q4, this short-term holding has been held for 7 quarters.

Based on 13F filings, Jeremy Grantham has maintained this position in WST for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 5,660 shares. Largest reduction occurred in Q4 2020, reducing 9,922 shares.

Analysis based on 13F filings available since 2013 Q2

Jeremy Grantham's West Pharmaceutical Services (WST) Holding Value Over Time

Track share changes against reported price movement

Quarterly West Pharmaceutical Services (WST) Trades by Jeremy Grantham

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2026 +5,660 New Buy 5,660 $359.00
Q1 2021 -1,297 Sold Out 0 $0.00
Q4 2020 -9,922 Reduce 88.44% 1,297 $282.96
Q2 2020 -600 Reduce 5.08% 11,219 $227.20
Q1 2020 +3,600 Add 43.80% 11,819 $152.21
Q4 2019 +8,219 New Buy 8,219 $150.38

Jeremy Grantham's West Pharmaceutical Services Investment FAQs

Jeremy Grantham first purchased West Pharmaceutical Services, Inc. (WST) in Q4 2019, acquiring 8,219 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Jeremy Grantham has held West Pharmaceutical Services, Inc. (WST) for 7 quarters since Q4 2019.

Jeremy Grantham's largest addition to West Pharmaceutical Services, Inc. (WST) was in Q4 2019, adding 8,219 shares worth $1.24 M.

According to the latest 13F filing for Q2 2026, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 5,660 shares of West Pharmaceutical Services, Inc. (WST), valued at approximately $2.03 M.

As of the Q2 2026 filing, West Pharmaceutical Services, Inc. (WST) represents approximately 0.00% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.

Jeremy Grantham's peak holding in West Pharmaceutical Services, Inc. (WST) was 11,819 shares, as reported at the end of Q1 2020.